Zebra Capital Management LLC Durect Corp Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.55 - $0.98 $26,205 - $46,693
-47,646 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.86 - $2.87 $88,621 - $136,744
47,646 New
47,646 $94,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
593K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $175M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email